Netherlands· NL-08ea8aa23dcd
Radelumin 2000 MBq/ml oplossing voor injectie
A psma-1007 18f product containing psma-1007 (18f), registered in Netherlands by ABX advanced biochemical compounds, Biomedizinische Forschungsreagenzien GmbH. The same ATC class is registered in 4 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Psma-1007 18f is registered in 4 of 19 countries.
Countries holding a registration under ATC V09IX17 (psma-1007 18f), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Psma-1007 18f · ATC V09IX17
4 / 19 countries
- Belgiumprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PSMA-1007 (18F)
- Manufacturer
- ABX advanced biochemical compounds, Biomedizinische Forschungsreagenzien GmbH
- Country
- Netherlands (NL)
- ATC code
- V09IX17
- ATC class
- PSMA-1007 18F
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id130644
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09IX17
Psma-1007 18f, as other registers publish it.
- Switzerland18F-PSMA-1007 ZRP ≥ 40 MBq / mL, InjektionslösungUniversitätsspital Zürich
- BelgiumRadelumin 1300 MBq/mlAbx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien
- PolandRadelumin 1300 MBq/mlAbx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH
- NetherlandsRadelumin 1300 MBq/ml oplossing voor injectieABX advanced biochemical compounds, Biomedizinische Forschungsreagenzien GmbH
- SwitzerlandRadelumin 200 - 4500 MBq/ml, InjektionslösungPosimed Radiopharm AG
- BelgiumRadelumin 2000 MBq/mlAbx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien
- PolandRadelumin 2000 MBq/mlAbx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH
- SwitzerlandSWAN-PSMA-1007 1 ml / 10 ml, InjektionslösungSWAN Isotopen AG SWAN Haus, Inselspital
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce4d1b7b-e6c6-42a1-9cdb-6873ec0d38a1 GET /v1/drugs/ce4d1b7b-e6c6-42a1-9cdb-6873ec0d38a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130644_smpc.pdf",
"strength": null,
"atc_label": "Psma-1007 (18 F)",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130644",
"excipients": [
"DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
"ETHANOL",
"KALIUMCHLORIDE (E 508)",
"KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
"NATRIUMASCORBAAT (E 301)",
"NATRIUMCHLORIDE",
"WATER VOOR INJECTIE"
],
"substances": [
"PSMA-1007 (18F)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130644.pdf",
"authorised_at": "2023/04/04",
"procedure_number": "FR/H/0797/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "130644",
"additional_monitoring": "Y"
}See everything about psma-1007 18f.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.